Clinical trial
Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral…
NCT00367276 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00367276 |
|---|---|
| Title | Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life. |
| Official title | A Multicentre, Open, Uncontrolled Study to Assess Quality of Life During Six Cycles (24 Weeks) of Treatment With an Oral Contraceptive Containing 30 µg of Ethinylestradiol and 3 mg of Drospirenone (Yasmin). |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131) |
| Enrollment | 221 |
| Start date | Dec 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Aug 22, 2006 |
| Last update posted | Oct 11, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: